|

Midazolam Nasal Spray 0.9 mg/spray Clinical Trials

1 actively recruiting trial

Pipeline

Phase 2: 1

Top Sponsors

  • Insel Gruppe AG, University Hospital Bern1

Indications

  • Acute Anxiety1
  • Palliative Care1
  • Anxiety1

Other1 trial

Administration of Intranasal Midazolam for Anxiety in Palliative Care
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.